Cardiac Failure Review

Scope & Guideline

Innovating the future of heart health.

Introduction

Explore the comprehensive scope of Cardiac Failure Review through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Cardiac Failure Review in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2057-7540
PublisherRADCLIFFE CARDIOLOGY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationCARD FAIL REV / Card. Fail. Rev.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIT F, BOURNE END BUSINESS PARK, BOURNE END, BUCKS SL8 5AS, ENGLAND

Aims and Scopes

The journal 'Cardiac Failure Review' is dedicated to advancing the understanding and management of heart failure through a comprehensive examination of its various aspects. The focus encompasses clinical, epidemiological, and therapeutic dimensions of heart failure, with an emphasis on innovative treatment strategies, diagnostic advancements, and patient-centered care.
  1. Heart Failure Management and Therapy:
    The journal emphasizes the latest developments in the management and therapeutic approaches to heart failure, including pharmacological treatments, device therapies, and patient education.
  2. Diagnostic Imaging and Biomarkers:
    A significant focus is placed on advancements in diagnostic imaging techniques and the identification of biomarkers that aid in the early detection, prognosis, and management of heart failure.
  3. Epidemiology and Public Health:
    Research published in the journal often addresses the epidemiological aspects of heart failure, including its global burden, demographic variations, and the impact of socioeconomic factors on patient outcomes.
  4. Multidisciplinary Approaches to Heart Failure Care:
    The journal highlights the importance of a multidisciplinary approach in heart failure management, integrating insights from cardiology, nursing, pharmacy, and public health.
  5. Emerging Therapies and Technologies:
    Innovations in treatment modalities, such as telemedicine and remote monitoring technologies, are explored to enhance patient management and outcomes.
The 'Cardiac Failure Review' has reflected emerging trends in heart failure research, highlighting new areas of focus that are gaining traction among researchers and clinicians. These trends indicate a shift towards more personalized, innovative, and comprehensive care models for heart failure patients.
  1. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF has surged, focusing on its unique challenges, treatment strategies, and the importance of this condition in the broader context of heart failure management.
  2. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote patient monitoring technologies has become increasingly prominent, particularly in light of the COVID-19 pandemic, emphasizing the need for innovative care solutions.
  3. Diversity and Health Disparities:
    There is a growing emphasis on understanding and addressing health disparities in heart failure care, particularly among minority populations, highlighting the importance of equitable healthcare access.
  4. Biomarkers and Personalized Medicine:
    The exploration of biomarkers for early detection and personalized treatment strategies is on the rise, reflecting a shift towards tailored therapy based on individual patient profiles.
  5. Multimodality Imaging:
    The use of multimodality imaging techniques to enhance diagnosis and treatment planning in heart failure is emerging as a critical theme, showcasing advancements in imaging technologies.

Declining or Waning

Over recent years, certain themes within the 'Cardiac Failure Review' have shown a decline in publication frequency, suggesting a shift in focus or a saturation of research in those areas. This decline may reflect evolving priorities in heart failure research or advancements that have rendered some topics less critical.
  1. Traditional Pharmacotherapy:
    While traditional pharmacotherapy for heart failure remains important, there has been a noticeable decline in articles focused on older classes of medications, as newer therapies and treatment strategies gain prominence.
  2. Basic Pathophysiological Studies:
    Research centered on basic pathophysiological mechanisms of heart failure has decreased, possibly due to a growing emphasis on clinical applications and translational research.
  3. Generalized Management Guidelines:
    Publications that reiterate general heart failure management guidelines without new insights or data have diminished, as the field moves towards more personalized and patient-specific treatment approaches.

Similar Journals

Korean Circulation Journal

Advancing Cardiovascular Knowledge, One Study at a Time.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Journal fur Kardiologie

Illuminating the Path of Cardiovascular Innovation.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Revista Portuguesa de Cardiologia

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Revista de la Federacion Argentina de Cardiologia

Exploring breakthroughs in cardiology for global impact.
Publisher: FEDERACION ARGENTINA CARDIOLOGIAISSN: 0326-646XFrequency: 4 issues/year

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

TEXAS HEART INSTITUTE JOURNAL

Empowering Healthcare Professionals with Essential Heart Insights.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

PROGRESS IN PEDIATRIC CARDIOLOGY

Advancing Pediatric Heart Health for Tomorrow's Generations
Publisher: ELSEVIER IRELAND LTDISSN: 1058-9813Frequency: 4 issues/year

PROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.

IJC Heart & Vasculature

Pioneering Insights for Heart Health Excellence
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

KARDIOLOGIYA

Connecting Scholars, Transforming Cardiac Care
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

International Journal of Cardiology

Pioneering Discoveries in Cardiovascular Medicine
Publisher: ELSEVIER IRELAND LTDISSN: 0167-5273Frequency: 24 issues/year

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

JACC-Cardiovascular Imaging

Pioneering Insights in Diagnostic Imaging
Publisher: ELSEVIER SCIENCE INCISSN: 1936-878XFrequency: 12 issues/year

JACC-Cardiovascular Imaging, published by Elsevier Science Inc, is a premier journal that focuses on the rapidly evolving field of cardiovascular imaging, providing a vital platform for the dissemination of high-quality research and clinical studies. With an impressive impact factor and ranking within the top tier of cardiology and radiology specialties, the journal is recognized for its commitment to advancing knowledge in diagnostic imaging techniques, including echocardiography, MRI, and CT in cardiovascular contexts. Since its inception in 2008 and converging through 2024, JACC-Cardiovascular Imaging has maintained a distinguished position, currently ranking Q1 both in Cardiology and Cardiovascular Medicine as well as in Radiology, Nuclear Medicine and Imaging. This ensures its relevance and influence, as evidenced by its Scopus rankings—ranked #2 in Radiology and #8 in Cardiology, placing it in the top echelons of scholarly output. Although it does not offer open access, the journal's content is crucial for researchers, clinicians, and students who seek to remain at the forefront of cardiovascular imaging advancements.